Cerevel, a biotech firm, recovered part of its Tuesday gains following positive test findings for a schizophrenia medicine./n
Read MoreThis Biotech Stock Doubled Overnight — And Then Hit A Deep Snag
2021-06-30T20:42:53-04:00June 30th, 2021|
Cerevel, a biotech firm, recovered part of its Tuesday gains following positive test findings for a schizophrenia medicine./n
Read More